Avon Technologies Share Discussion Threads

[jdh1602] 12/11/2021 10:01

Fun facts - Avon was a Buy twice in last 6 months, in both IC and Shares Magazine, and a Buy on Naked Trader's website in September. I track this stuff carefully. Thanks guys!!

[jdh1602] 12/11/2021 09:48

IC had Avon's 12-month Fwd PE at 21 in that article. So it might be less now after the share price drop, but depending on what the real 2022 earnings turn out to be, and the prospects for the future. As always, too many variables that are unknown at this point after the RNS bombshell!

[dope007] 12/11/2021 09:30

The stock is still trading multiple of sales jdh1602. It is still very expensive

[jdh1602] 12/11/2021 09:23

According to IC last week (when share price was 1945), 2022 forecast Sales were $238m. Today's release is saying $40m is under threat. That's 17% of revenue under threat, but not already written off. The share price is now 42% lower, at 1100. Over-reaction?

[saltaire111] 12/11/2021 09:12

Oh dear. Trouble at t’mill.

Avon Protection plc

Body armor strategic review

Avon Protection plc ("Avon Protection" or "the Group") today provides an update on its body armor business.

Body armor update

Following the contract awards for the U.S. Defense Logistics Agency ("DLA") Enhanced Small Arms Protective Inserts ("ESAPI") and U.S. Army Vital Torso Protection ("VTP") ESAPI body armor plates, we have been engaged with our customers to complete the necessary product approval processes. Disappointingly, the VTP ESAPI plates have encountered a failure in First Article Testing which will significantly delay the likely approval timetable for this product.

Separately, we have experienced further delays in obtaining final product approvals for the DLA ESAPI body armor plates, with approvals for this product now expected in the second quarter of our financial year ending 30 September 2022 ("FY22").

Strategic review of body armor business

In light of these challenges, the Board has initiated a strategic review of our body armor business.

Our FY22 revenue guidance included approximately $40 million of body armor revenue. In light of the above, the financial contribution from our body armor business in FY22 and beyond will be significantly reduced, with the ultimate impact, including any associated cost savings, depending on the outcome of the review process.

These issues and the strategic review are restricted to the body armor business, with the Group's leading respiratory protection and helmet product portfolios unaffected.

Delay to FY21 results announcement

Our underlying trading results for FY21 are expected to be in line with the guidance set out in the post close trading update of 13 October 2021.

We have delayed the announcement of our FY21 results, initially planned for 23 November 2021, to allow for a review of the carrying value of the assets related to the body armor business and the additional audit work arising from this post balance sheet event.

We will confirm a revised announcement date, which we expect to be in early December, as soon as practicable. We will include an update on our strategic review of our body armor business and provide updated guidance for FY22 and beyond alongside our FY21 results announcement.

Salty

[robinnicolson] 12/11/2021 09:10

Jefferies estimates the risk to FY22/23 forecast consensus EBITDA could be up to 10-15%.

It's the reputational damage that is currently most concerning to me as a shareholder.

[buywell3] 12/11/2021 08:38

buywell3 16 Aug '21 - 02:34 - 278 of 412 Edit

Skid marks on this chart imo



free stock charts from uk.advfn.com


Wonder if this got read much ?



Supply chain disruptions seem to be very much en vogue

[p1nkfish] 12/11/2021 08:36

Money best allocated elsewhere for quite a while.

[buywell3] 12/11/2021 08:33

buywell3 23 Oct '21 - 22:27 - 382 of 409 Edit

buywell can't see a chart bottom as yet which is somewhat of a concern imo

[dope007] 12/11/2021 08:30

Based on sales v mkt cap this still has at least another 50% drop in it

[pdwop] 12/11/2021 08:29

Destruction of shareholder value and huge reputational damage. Repeat orders??

[cassini] 12/11/2021 08:27

This has another couple of days of price falls in it probably.

May be better to wait until next week if looking to buy.

[dope007] 12/11/2021 08:26

And this is the problem with expensive stocks. Disappointment kills the price

[solo4yous] 12/11/2021 08:26

Massive drop in AVON wow

Meanwhile people are accumulating

81% been held at June reporting data/date... remarkably more popular than the share price is saying:

[jdh1602] 12/11/2021 08:26

I go with 1190 to settle in the next few days

[gripfit] 12/11/2021 08:25

im in at £7.50..

[newbold120] 12/11/2021 08:20

850p I thought was likely

[jdh1602] 12/11/2021 08:18

Correction - 2017!

[jdh1602] 12/11/2021 08:18

Back to 2018 breakout level! Must be a value hold now.

[mattboxy] 12/11/2021 08:10

35% down as we speak

[scepticalinvestor] 12/11/2021 08:08

i have had this on my watchlist for a while. Now highly overvalued - looking for a sub 1000p entry...